Yannis Skoufalos - Procter Gamble Global Product Supply Officer

PGCO34 Stock  BRL 59.00  0.11  0.19%   

Executive

Ms. Yannis Skoufalos is the Global Product Supply Officer of the Procter Gamble Company. She was First Elected to Officer Position in 2011. since 2011.
Age 60
Tenure 13 years
Phone513 983 1100
Webhttps://www.pginvestor.com

Procter Gamble Management Efficiency

The company has return on total asset (ROA) of 0.0955 % which means that it generated a profit of $0.0955 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.3202 %, meaning that it generated $0.3202 on every $100 dollars invested by stockholders. Procter Gamble's management efficiency ratios could be used to measure how well Procter Gamble manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 22.85 B in total debt with debt to equity ratio (D/E) of 54.4, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Procter Gamble has a current ratio of 0.77, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Procter Gamble until it has trouble settling it off, either with new capital or with free cash flow. So, Procter Gamble's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Procter Gamble sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Procter to invest in growth at high rates of return. When we think about Procter Gamble's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 5 records

EXECUTIVE Age

Julio CamaraMundial SA
N/A
Lineu OliveiraBombril SA
63
Marcos ScaldelaiBombril SA
N/A
Andrea RibeiroBombril SA
N/A
Julio CamaraHrcules SA
N/A
The Procter Gamble Company provides branded consumer packaged goods to consumers in North America, Europe, the Asia Pacific, Greater China, Latin America, India, the Middle East, and Africa. The Procter Gamble Company was founded in 1837 and is headquartered in Cincinnati, Ohio. PG DRN operates under Household Personal Products classification in Brazil and is traded on Sao Paolo Stock Exchange. It employs 92000 people. The Procter Gamble (PGCO34) is traded on Sao Paulo Exchange in Brazil and employs 106,000 people.

Management Performance

Procter Gamble Leadership Team

Elected by the shareholders, the Procter Gamble's board of directors comprises two types of representatives: Procter Gamble inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Procter. The board's role is to monitor Procter Gamble's management team and ensure that shareholders' interests are well served. Procter Gamble's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Procter Gamble's outside directors are responsible for providing unbiased perspectives on the board's policies.
Kathleen Fish, CTO
Matthew Janzaruk, VP Officer
Mary FergusonMcHugh, Group President - Global Family Care and Global Brand Creation and Innovation, P&G Ventures
Kenneth Chenault, Independent Director
Amy Chang, Independent Director
Nelson Peltz, Director
Martin Riant, Group President of Global Baby, Feminine and Family Care
Hatsunori Kiriyama, President - Asia
Magesvaran Suranjan, President - Asia Pacific Selling and Market Operations
Francis Blake, Director
Tarek Farahat, President - Latin America
Mohamed Samir, President - India, Middle East and Africa
Alexandra Keith, President - Global Hair Care and Beauty Sector
Susan DesmondHellmann, Independent Director
Valarie Sheppard, Principal Accounting Officer, Sr. VP, Comptroller and Treasurer
Margaret Whitman, Independent Director
Walter McNerney, Lead Independent Director
Terry Lundgren, Independent Director
Angela Braly, Independent Director
Giovanni Ciserani, Group President of Global Fabric and Home Care
James McNerney, Lead Independent Director
Ernesto Zedillo, Independent Director
Steven Bishop, Group President - Global Health Care
Scott Cook, Independent Director
Ernesto Leon, Independent Director
Susan Whaley, Chief Sec
Yannis Skoufalos, Global Product Supply Officer
Linda ClementHolmes, CIO
John Chevalier, Director - Investor Relations
Juan Posada, President - Latin America Selling and Market Operations
Fatima Francisco, Feminine Baby
Alan Lafley, Chairman, CEO and President and Member of Proxy Committee
Jeffrey Schomburger, Global Sales Officer
Vittorio Cretella, Chief Officer
Patricia Woertz, Independent Director
Shailesh Jejurikar, Chief Officer
Andre Schulten, Chief Officer
Marc Pritchard, Global Brand Building Officer
David Taylor, Group President - Global Health and Grooming
Mark Biegger, Global Human Resources Officer
Joseph Jimenez, Director
Matthew Price, President - Greater China Selling and Market Operations
Julio Nemeth, President - Global Business Services
Deborah Majoras, Chief Legal Officer, Secretary
Jon Moeller, CEO Pres
Charles Pierce, Group President - Global Grooming
Gary Coombe, President - Europe Selling and Market Operations
Carolyn Tastad, Global Customer Business Development Officer
Ken Patel, Chief Counsel

Procter Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Procter Gamble a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Procter Gamble using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in The Procter Gamble. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.
For information on how to trade Procter Stock refer to our How to Trade Procter Stock guide.
Note that the Procter Gamble information on this page should be used as a complementary analysis to other Procter Gamble's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Complementary Tools for Procter Stock analysis

When running Procter Gamble's price analysis, check to measure Procter Gamble's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Procter Gamble is operating at the current time. Most of Procter Gamble's value examination focuses on studying past and present price action to predict the probability of Procter Gamble's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Procter Gamble's price. Additionally, you may evaluate how the addition of Procter Gamble to your portfolios can decrease your overall portfolio volatility.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Money Managers
Screen money managers from public funds and ETFs managed around the world
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
CEOs Directory
Screen CEOs from public companies around the world
Bonds Directory
Find actively traded corporate debentures issued by US companies
Please note, there is a significant difference between Procter Gamble's value and its price as these two are different measures arrived at by different means. Investors typically determine if Procter Gamble is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Procter Gamble's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.